Skip to main content

Clinical trial AURA

Avelumab as neoadjuvant therapy in subjects with urothelial muscle invasive bladder cancers

Organ Ureters - bladder - urethra
Trial status Trial closed for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor Institut Jules Bordet
EudraCT Identifier 2017-002758-35
Inclusion criteria Non metastatic urothelial carcinoma candidate for surgeryCisplatin eligible and ineligible
Last update